A phytosterol-enriched saw palmetto supercritical CO2 extract ameliorates testosterone-induced benign prostatic hyperplasia by regulating the inflammatory and apoptotic proteins in a rat model
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A phytosterol-enriched saw palmetto supercritical CO2 extract ameliorates testosterone-induced benign prostatic hyperplasia by regulating the inflammatory and apoptotic proteins in a rat model
Authors
Keywords
-
Journal
BMC Complementary and Alternative Medicine
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-17
DOI
10.1186/s12906-019-2697-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis
- (2017) Shaun Wen Huey Lee et al. Scientific Reports
- EVALUATION OF THE ANTI-INFLAMMATORY CAPACITY OF BETA-SITOSTEROL IN RODENT ASSAYS
- (2016) Rogelio Paniagua-Pérez et al. African Journal of Traditional Complementary and Alternative Medicines
- Benign prostatic hyperplasia
- (2016) Bilal Chughtai et al. Nature Reviews Disease Primers
- Different lasers in the treatment of benign prostatic hyperplasia: a network meta-analysis
- (2016) Xingming Zhang et al. Scientific Reports
- A synopsis of drugs currently in preclinical and early clinical development for the treatment of benign prostatic hyperplasia
- (2015) Kanika Gupta et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- What do we know about phytotherapy of benign prostatic hyperplasia?
- (2015) Olta Allkanjari et al. LIFE SCIENCES
- Effects of hexanic extract of serenoa repens (permixon®160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia
- (2015) Alain Latil et al. PROSTATE
- Dutasteride for the treatment of benign prostatic hyperplasia
- (2013) Christopher Wu et al. EXPERT OPINION ON PHARMACOTHERAPY
- Effect of Boerhaavia diffusa in experimental prostatic hyperplasia in rats
- (2013) BhavinA Vyas et al. INDIAN JOURNAL OF PHARMACOLOGY
- Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)
- (2011) J. Curtis Nickel et al. BJU INTERNATIONAL
- Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
- (2011) Silvia Paba et al. CURRENT PHARMACEUTICAL DESIGN
- The functional role of reactive stroma in benign prostatic hyperplasia
- (2011) Isaiah G. Schauer et al. DIFFERENTIATION
- Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate
- (2010) Gonzalo Rodríguez-Berriguete et al. BMC CANCER
- Male Lower Urinary Tract Symptoms (LUTS) and Benign Prostatic Hyperplasia (BPH)
- (2010) Claus G. Roehrborn MEDICAL CLINICS OF NORTH AMERICA
- Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies
- (2010) F L Bishop et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Pharmacological effects of saw palmetto extract in the lower urinary tract
- (2009) Mayumi Suzuki et al. ACTA PHARMACOLOGICA SINICA
- β-Sitosterol exhibits anti-inflammatory activity in human aortic endothelial cells
- (2009) Stella Loizou et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Inflammation in benign prostatic hyperplasia: A 282 patients' immunohistochemical analysis
- (2009) Grégoire Robert et al. PROSTATE
- Prostate growth and inflammation
- (2007) Alessandro Sciarra et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started